We are proud to announce that PhenoPath is now a Quest Diagnostics Company.
IHC
Methodology: IHC
Clinical Significance:
Identifies renal cell carcinoma, as well as other clear cell carcinomas, e.g., from urothelium and adrenal cortex. May also provide prognostic information in CRCC, with low CA-IX expression correlating with poor survival.
Subcellular Localization: Cytoplasmic and membranous
Organ: Genitourinary Tumors
Disease State:
CPT Code(s): 88342 or 88341 (reference only; CPTs may vary)
Turnaround Time: Within 1-2 business days of receipt
Schedule: Monday - Friday
Specimen Requirements:
• Formalin-fixed, paraffin-embedded (FFPE) tissue block or cell block - OR -
• 1 unstained slide for each test requested plus 3-4 additional unstained slides cut at 4µm